Back to results
US 7,252,957 B2Granted
Identification of etiology of autism
AssigneeImmunosciences Lab, Inc.
InventorAristo Vojdani
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method for following up a prognosis of children with autism before and after treatment with different modalities administered by their clinicians, confirming the involvement of infectious agents, dietary proteins, and toxic chemicals in development of autism. The method utilizes detection of increased amounts of antibodies against an antigen based on infectious agent, toxic chemicals, or dietary proteins. Another method utilizes detection of antibodies to a self-tissue or peptide.
Claims7
A method for diagnosing an autistic spectrum disorder in a patient, comprising the steps of:
- a) determining a level of antibodies to a protein selected from the group consisting of an aminopeptidase N (CD13), dipeptidyl peptidase IV (CD26), dipeptidyl peptidase I and CD69, in one or more samples from the patient;
- and
- b) comparing the level of antibodies determined in step a) with a normal level of the antibodies from control subjects, wherein
- (i) normal level or lower than normal levels of antibodies indicate absence of autistic spectrum disorder in said patient;
- and
- (ii) higher than normal level of the antibodies indicates the presence of the autistic spectrum disorder in said patient.
3 more elements
Dependencies are inferred from the claim text.